Trial intelligence / Profile preview

Beta-Blockade in Elderly Trauma Patients

NCT00302692Phase 2Unknown

Sponsor
UT Southwestern Medical Center
Start
Dec 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, open-label trial of esmolol and metoprolol in multiple trauma (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: Mortality and Cardiovascular Morbidity. Status: unknown.

02

Drugs

esmololmetoprolol
03

Conditions

multiple trauma

Beyond the preview

Go deeper on NCT00302692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00302692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call